Thermo Fisher Scientific (TMO) Acquires Affinity BioReagents
More News related to TMO
- Thermo Fisher Scientific to Present at Thomas Weisel Partners Healthcare Conference
- Thermo Fisher Scientific and Toronto's University Health Network Collaborate in Pioneering Biomarker Research
- Temoris Resources Inc.: Beverdell
- Temoris Resources Inc.: Beverdell
- Thermo Fisher Scientific Showcases Range of Clinical Diagnostics Solutions at AACC 2008
Thermo Fisher Scientific Inc. (NYSE: TMO) has acquired Affinity BioReagents, a provider of antibodies, peptides, proteins and other reagents for life science research, based in Golden, Colorado.
Affinity BioReagents had annual revenues of approximately $6 million in 2007, and will be integrated into Thermo Fisher's Analytical Technologies Segment.
Terms not disclosed.
Thermo Fisher Scientific Inc. (Thermo Fisher) is engaged in serving science. The Company serves its customers through two principal brands: Thermo Scientific and Fisher Scientific. [SM]
Related Categories
Mergers and AcquisitionsStocks Mentioned
-0.67Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
